Veradermics Cash Flow Statement (2025-2026) | MANE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2025 Mar2026
Operating Activities
Net Income (Quarter) -12.40M-27.23M
Share-based Compensation (Quarter) 0.21M5.26M
Gains from Investment Securities (Quarter) -0.01M
Change in Interest Receivables (Quarter) 1.50M
Cash from Operations (Quarter) -13.32M-21.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.07M
Change in Working Capital
Change in Account Payables (Quarter) -0.69M-1.05M
Change in Accured Expenses (Quarter) -0.01M-0.01M
Investing Activities
Capital Expenditures (Quarter) 0.02M
Change in Acquisitions & Divestments (Quarter) 21.69M
Cash from Investing Activities (Quarter) -15.75M-101.30M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter) 0.01M
Preferred Shares Issued (Quarter) 8.42M
Misc.
Cash from Financing Activities (Quarter) 8.42M269.11M
Change in Cash (Quarter) -20.64M146.65M
Free Cash Flow (Quarter) -13.34M-21.17M
Net Cash Flow (Quarter) -20.64M146.65M